WHO WE ARE 

We are a group of experienced pharmaceutical and biotech executives who are passionate about portfolio decision making to accelerate the pipeline of medicines to patients. Our portfolio is liver-disease focused. We are thrilled to be part of an experienced team and eager to develop our programs.

 
 
2024-04 BPH Team Photo.jpg
 
 

OUR VALUES
What we stand for


COMMITMENT TO PATIENTS
Helping patients suffering from liver disease is core to our mission


DECISIVELY INNOVATIVE
Applying science to innovatively develop our differentiated medicines is what motivates us every day


PURPOSEFUL URGENCY
We apply our expertise, learn, adapt and innovate, to make rigorous and timely decisions. Patients are waiting and every day counts


PASSION FOR EXCELLENCE
We strive to be the best in what we do and focus on doing the right things, right!


ONE TEAM
We are one team united by shared mission, passion, trust and camaraderie

 
 
Screenshot 2023-12-04 at 11.11.57.png
 

LEADERSHIP

 
 

Sophie Kornowski, PharmD

Chief Executive Officer

Scott Allen

Chief Financial Officer

Haroon Hashmi, PhD

Chief Regulatory and Technical Officer

Amanda Kunevich

Chief People Officer

Matthew Bryant, PharmD

VP Medical Affairs

 
 

MANAGEMENT TEAM

 
 

Tatjana Odrljin, MD, PhD

VP Clinical Development

Brenda Jeglinski

VP Clinical Operations

Alicia Clawson

VP Biometrics

 
 
 

Gerard Bain, PhD

VP Biomarker Discovery & Development

Yvonne Van Gessel, DVM

VP Preclinical Safety

 
 
 
 
 
 

BOARD OF DIRECTORS

 
 

Stefan Meister

Chairman of the Board

Sophie Kornowski, PharmD

Chief Executive Officer

Elias Zerhouni, MD

Board Member and Scientific Advisor

Travis Wilson

Board Member and Technical Advisor

Cyrus Jilla

Board Member